Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 26

1.

Mactinin, a fragment of cytoskeletal alpha-actinin, is a novel inducer of heat shock protein (Hsp)-90 mediated monocyte activation.

Luikart SD, Panoskaltsis-Mortari A, Hinkel T, Perri RT, Gupta K, Oegema TR, Gupta P.

BMC Cell Biol. 2009 Aug 28;10:60. doi: 10.1186/1471-2121-10-60.

2.

High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150.

Lichtman SM, Petroni G, Schilsky RL, Johnson JL, Perri RT, Niedzwiecki D, Sklar J, Barcos M, Peterson BA.

Leuk Lymphoma. 2001 Nov-Dec;42(6):1255-64.

PMID:
11911406
3.

Fine needle aspiration of signet-ring cell lymphoma. A case report with differential diagnostic considerations.

Gilcrease MZ, Sahin M, Perri RT, Nelson FS, Guzman-Paz M.

Acta Cytol. 1998 Nov-Dec;42(6):1461-7.

PMID:
9850663
4.

Carboplatin in previously treated multiple myeloma. A Cancer and Leukemia Group B phase II trial.

Omura GA, Perri RT, Peterson B, Schiffer CA.

Am J Clin Oncol. 1994 Jun;17(3):196-8.

PMID:
8192102
5.

Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell and immunoblastic lymphomas.

Niehans GA, Jaszcz W, Brunetto V, Perri RT, Gajl-Peczalska K, Wick MR, Tsuruo T, Bloomfield CD.

Cancer Res. 1992 Jul 1;52(13):3768-75.

6.
7.
8.

Immunobiology of malignant B cells and immunoregulatory cells in B-chronic lymphocytic leukemia.

Kay NE, Perri RT.

Clin Lab Med. 1988 Mar;8(1):163-77. Review.

PMID:
2896087
9.

Natural killer function in B-chronic lymphocytic leukemia.

Kay NE, Perri RT.

Nouv Rev Fr Hematol. 1988;30(5-6):343-5. Review.

PMID:
3065733
10.

In vitro correlates of low dose ara-C efficacy: clinical, cytogenetic, and bone marrow culture analysis.

Weisdorf DJ, Perri RT, Arthur DC, Machnicki JL, Oken MM, Miller WJ.

Am J Hematol. 1987 May;25(1):43-53.

PMID:
3578263
12.

Abnormal T cell function in early-stage chronic lymphocytic leukemia (CLL) patients.

Perri RT, Kay NE.

Am J Hematol. 1986 May;22(1):55-61.

PMID:
3513551
14.
16.

Low-dose ARA-C fails to enhance differentiation of leukaemic cells.

Perri RT, Weisdorf DJ, Oken MM.

Br J Haematol. 1985 Apr;59(4):697-701.

PMID:
3886002
17.

Laminin selectively enhances monocyte-macrophage-mediated tumoricidal activity.

Perri RT, Vercellotti G, McCarthy J, Vessella RL, Furcht LT.

J Lab Clin Med. 1985 Jan;105(1):30-5.

PMID:
3968463
18.

Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.

Perri RT, Allen JI, Oken MM, Limas C, Kay NE.

Med Pediatr Oncol. 1985;13(3):122-5.

PMID:
3838792
19.

The influential T cell in B-cell neoplasms.

Kay NE, Oken MM, Perri RT.

J Clin Oncol. 1983 Dec;1(12):810-6. Review.

PMID:
6230420
20.

Alterations in human natural killer cell activity and monocyte cytotoxicity induced by zinc deficiency.

Allen JI, Perri RT, McClain CJ, Kay NE.

J Lab Clin Med. 1983 Oct;102(4):577-89.

PMID:
6604771
Items per page

Supplemental Content

Loading ...
Support Center